Surgical Robots Market size : USD 14.06 Billion in 2025 to USD 34.75 Billion by 2032 at 13.8% CAGR

Market Overview

The Surgical Robots Market size was valued at USD 14.06 Billion in 2025 and total revenue is expected to grow at a CAGR of 13.8% from 2026 to 2032, reaching nearly USD 34.75 Billion. Surgical robots are computer-controlled systems that assist surgeons in positioning and manipulating instruments during complex procedures. MMR highlights their role in addressing limitations of conventional laparoscopic and thoracoscopic techniques through greater precision, smaller incisions, improved dexterity and three-dimensional visualization.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/22528/

Robotic-assisted procedures are expanding across urology, gynecology, orthopedics and general surgery. MMR expects the clinical footprint to increase as procedure volumes rise, new platforms emerge and hospitals expand implementation. Miniaturization, improved motors, compact materials, sophisticated controls and safety mechanisms are supporting minimally invasive surgery, while growing use in ambulatory surgical centers is broadening access beyond traditional inpatient settings.

Key Growth Drivers Fueling the Surgical Robots Market

Minimally invasive surgery adoption: Robotic surgery supports precise instrument placement, smaller incisions and controlled movement. MMR links these capabilities with reduced tissue damage, lower postoperative discomfort and wider adoption of minimally invasive procedures.

Expanding hospital implementations: Hospitals have larger budgets, access to financing and surgical volumes that help justify high-cost robotic systems. Integration across general surgery, orthopedics, gynecology and urology increases platform utilization.

Ambulatory surgical center adoption: MMR identifies growing use of robotics in ASCs as an important trend. Outpatient facilities create a broader opportunity for compact and cost-effective systems as more procedures move beyond inpatient settings.

Orthopedic robotics: Robotic technologies are increasingly paired with knee and hip implant portfolios to improve surgical planning and placement. MMR highlights orthopedic franchises and next-generation robotic platforms as continuing investment areas.

Technology and platform innovation: Miniature in-vivo robots, enhanced 3D imaging, improved instrument control and digital surgery are creating opportunities. Continued medical-device investment is strengthening the transition from conventional laparoscopy toward digitally assisted procedures.

Market Segmentation  By Offering, Application & End-Use

• Instruments & Accessories  dominant offering: Includes robotic arms, surgical tools and disposable accessories; MMR expects this segment to dominate during the forecast period.
• Robotics Systems: Laparoscopic Robotic System, Orthopedic Robotic System, Neurosurgical Robotic System and Others.
• Services: Included within MMR's offering segmentation.
• Control Mechanism: Remote Controlled, Robotic Arm Controlled and Computer Assisted.
• Application: Neurology, Urology, Gynecology, Orthopedics and Others.
• Hospitals  dominant end user: Hospitals lead because of larger budgets, broad patient bases and complex procedure volumes.
• Other End Users: Ambulatory Surgical Centers and Specialty Clinics.
• MMR's public summary does not publish numerical percentage shares for these segments.

Instruments and accessories lead the Surgical Robots Market because essential tools and disposable components require replacement, sterilization or recurring use as procedure volumes increase. Hospitals remain the leading end-user setting, while ASCs represent an expanding adoption channel as robotic platforms become more suitable for outpatient workflows.

Regional Analysis  Where Is the Surgical Robots Market Growing Fastest?

United States

The United States is the main innovation hub identified within dominant North America. MMR states that about 65% of the world's surgical robots are installed in the United States and names Intuitive Surgical, Medtronic and Stryker among companies driving innovation.

United Kingdom

The United Kingdom is included in MMR's European coverage. The public summary does not disclose a standalone UK market size, share or CAGR.

Germany

Germany is included in MMR's European scope. No standalone German market size, share or growth rate is published in the public description.

Japan

Japan forms part of MMR's Asia-Pacific coverage. MMR notes that Stryker's Mako robotic surgery system received regulatory approval in Japan for a partial-knee indication in January 2022.

South Korea

South Korea is included within Asia Pacific. The public summary provides no separate South Korean value, percentage share or CAGR.

China

China is included in the Asia-Pacific regional analysis. MMR does not disclose a China-specific market value, share or forecast growth rate.

India

India is also covered within Asia Pacific. No standalone Indian market value, share or CAGR is published in MMR's public description.

North America is the dominant region and is expected to retain leadership. MMR does not explicitly identify a fastest-growing region in the public summary. The United States is the clearest disclosed investment hotspot because MMR states that about 65% of the world's installed surgical robots are located there.

Competitive Landscape  Leading Companies in the Surgical Robots Market

1. Intuitive Surgical, Inc.: MMR lists the U.S. company among major robotic-assisted surgical system manufacturers.
2. Medtronic plc: Listed among major platform manufacturers active in robotic-assisted surgery.
3. Johnson & Johnson: MMR lists Johnson & Johnson through Auris Health and Verb Surgical among robotic platform developers.
4. Asensus Surgical, Inc.: Included among robotic-assisted system manufacturers and associated with digitally enabled surgery.
5. Medrobotics Corporation: Listed among U.S.-based robotic platform manufacturers serving minimally invasive surgery.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/22528/

Recent Developments & Strategic Moves

• Acquisition: KARL STORZ completed its acquisition of Asensus Surgical in August 2024, combining endoscopy with robotic and digital surgery capabilities.
• AI partnership: CMR Surgical and NVIDIA showcased an intelligent-surgery simulation for Versius Plus in July 2026 using NVIDIA Isaac for Healthcare technology.
• Product and regulatory expansion: Johnson & Johnson received FDA De Novo authorization for OTTAVA in July 2026 for multiple upper-abdominal general-surgery procedures.
• Platform expansion: Intuitive received FDA clearance in January 2026 for da Vinci 5 in selected cardiac procedures.
• Government infrastructure: AIIMS Raipur inaugurated a government robotic surgery facility in September 2025, adding robotic-assisted services and training across several surgical specialties.

AI & Digital Transformation Impact on Surgical Robots Market

How is AI changing the Surgical Robots Market? AI is moving robotic platforms toward data-assisted decision support, machine vision and intelligent workflow optimization. MMR highlights the Intelligent Surgical Unit associated with the Senhance system as adding AI-based and machine-vision capabilities, showing how software can enhance visualization and system intelligence.

Current developments extend that direction. CMR Surgical and NVIDIA are exploring simulation environments in which robotic systems learn from surgical data and model how procedures could evolve. AI therefore complements surgeon control, with near-term applications in visualization, planning, prediction, workflow support and consistency.

Future Outlook Investment Opportunities & Emerging Trends in Surgical Robots Market

What is the future of the Surgical Robots Market? MMR points to a broader clinical footprint, rising general-surgery procedure volumes, miniature in-vivo robots, improved controls, advanced imaging and increased use in ASCs. Investment opportunities are developing around recurring instruments and accessories, more affordable platforms, orthopedic robotics, digital surgery and outpatient systems. North America remains the dominant disclosed region, while developers that reduce system cost and integrate software with precise robotic control are positioned for the next stage of adoption.

Expert Commentary

"According to Dharati Raut, Research Manager at Maximize Market Research, 'The Surgical Robots Market is projected to grow from USD 14.06 Billion in 2025 to nearly USD 34.75 Billion by 2032 at a CAGR of 13.8% from 2026 to 2032. Investment opportunities are increasingly tied to minimally invasive surgery, intelligent robotic platforms, recurring instruments and accessories, outpatient adoption and digitally connected surgical workflows as the clinical footprint of robotic surgery expands.'"

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com